The Urban Challenge Fund, with Rs. 1 lakh crore (US$ 10.71 billion) in central support, aims to catalyse Rs. 4 lakh crore (US$ 42.84 billion) in city infrastructure investments, with a strong focus on ...
Indian Railways has reached 99.6% electrification, carried 741 crore passengers in 2025-26, and is accelerating high-speed and digital rail modernisation with record capital support.
India’s exports touched Rs. 80.23 lakh crore (US$ 860.09 billion) in 2025-26, driven by strong services growth and steady performance in key merchandise sectors.
India’s automobile industry achieved record sales across all vehicle categories in 2025-26, supported by tax reforms, lower interest rates and strong export growth.
The Ministry of Commerce has launched a new integrated website and bilingual mobile app for the Department of Commerce, strengthening digital trade access, multilingual outreach and e-governance ...
L&T expects nuclear energy revenues to triple over the next five years as India accelerates its nuclear capacity roadmap towards 100 GW by 2047, supported by rising clean baseload power demand.
BMW expects luxury vehicles to account for 5% of India’s total car sales by 2030, supported by younger affluent buyers, premiumisation trends and improving infrastructure.
India’s mutual fund industry closed FY26 with AUM rising 12.2% to Rs. 73.73 lakh crore (US$ 790.07 billion), supported by record SIP inflows and strong equity participation despite market volatility.
India’s Software-Defined Vehicle Industry is driving EV growth through smart software, OTA updates, and connected mobility ...
Prime Minister Mr. Narendra Modi said India’s annual infrastructure spending has risen six-fold since 2014 to over Rs. 12 lakh crore (US$ 128.56 billion), strengthening logistics, connectivity and ...
India’s data centre market is projected to more than double to Rs. 20.53 lakh crore (US$ 22 billion) by 2030, driven by AI, cloud adoption and large-scale hyperscale investments.
India Pharma 2026 concluded with a strong call for enhanced funding, infrastructure and faster execution to drive innovation-led growth in pharmaceuticals, advanced therapeutics and biopharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results